Literature DB >> 1831604

Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis.

N G Guseva1, N V Anikina, R Myllylä, L Risteli, J Risteli, J V Chochlova, K I Kivirikko, V A Nassonova.   

Abstract

The concentrations of the amino terminal propeptide of type III procollagen, the 7S domain of type IV collagen, and the fragment P1 of laminin (PIIINP, 7S, and P1 respectively) and the activity of galactosylhydroxylysyl glucosyltransferase (GGT) in serum were evaluated as indicators of disease activity in a cross sectional study of 84 patients with progressive systemic sclerosis. The mean values of PIIINP, P1, and GGT were raised in progressive systemic sclerosis, 19-32% of patients having abnormal values of the various tests. PIIINP, measured with two different assays, and P1 were associated with active, acute, or subacute disease. GGT also correlated positively with some acute phase proteins in the whole group, without a clear association with the course of the disease. Arthritis was associated with increased PIIINP concentrations as well as with an increased activity of GGT. Kidney disease led to raised concentrations of the degradation products of PIIINP. Raynaud's phenomenon in the hands was related to increased PIIINP concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831604      PMCID: PMC1004462          DOI: 10.1136/ard.50.7.481

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Collagen glucosyltransferase. Partial purification and characterization of the enzyme from whole chick embryos and chick-embryo cartilage.

Authors:  R Myllylä; L Risteli; K I Kivirikko
Journal:  Eur J Biochem       Date:  1976-01-02

2.  Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.

Authors:  K D Bentsen; J H Henriksen; F Bendtsen; K Hørslev-Petersen; I Lorenzen
Journal:  Hepatology       Date:  1990-06       Impact factor: 17.425

3.  Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma.

Authors:  S Majewski; A Skiendzielewska; B Makieła; S Jablońska; M Błaszczyk
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.

Authors:  S A Jimenez; G Feldman; R I Bashey; R Bienkowski; J Rosenbloom
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

5.  Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.

Authors:  T Krieg; I Langer; H Gerstmeier; J Keller; H Mensing; G Goerz; R Timpl
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

6.  Analysis of extracellular matrix proteins in biological fluids.

Authors:  L Risteli; J Risteli
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Immunochemical properties of the aminopropeptide of procollagen type III.

Authors:  H Rohde; P Bruckner; R Timpl
Journal:  Eur J Biochem       Date:  1983-09-15

8.  Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Authors:  K Hørslev-Petersen; K D Bentsen; A Engström-Laurent; P Junker; P Halberg; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

9.  Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease.

Authors:  O Niemelä; L Risteli; E A Sotaniemi; J Risteli
Journal:  Eur J Clin Invest       Date:  1985-06       Impact factor: 4.686

10.  Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.

Authors:  K Hørslev-Petersen; T Ammitzbøll; A Engström-Laurent; K Bentsen; P Junker; G Asboe-Hansen; I Lorenzen
Journal:  J Rheumatol       Date:  1988-03       Impact factor: 4.666

View more
  4 in total

1.  Type IV collagen levels are elevated in the serum of patients with peritoneal dissemination of gastric cancer.

Authors:  Jun Kinoshita; Sachio Fushida; Shinichi Harada; Isamu Makino; Keishi Nakamura; Katsunobu Oyama; Hideto Fujita; Itasu Ninomiya; Takashi Fujimura; Masato Kayahara; Tetsuo Ohta
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

2.  Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome.

Authors:  B Stoiser; F Thalhammer; I El-Menyawi; A Wilfing; F Daxböck; G J Locker; H Burgmann
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease.

Authors:  H Burgmann; U Hollenstein; T Maca; K Zedwitz-Liebenstein; F Thalhammer; R Koppensteiner; H Ehringer; W Graninger
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

4.  Serum laminin in malaria.

Authors:  C Wenisch; W Graninger; C Viravan; S Looareesuwan; B Parschalk; W Wernsdorfer
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.